# Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction

> **NCT02901184** · PHASE3 · RECRUITING · sponsor: **Uppsala University** · enrollment: 2000 (estimated)

## Conditions studied

- Heart Failure With Preserved Ejection Fraction

## Interventions

- **DRUG:** Spironolactone
- **OTHER:** Standard care

## Key facts

- **NCT ID:** NCT02901184
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-11-23
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2024-10-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02901184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02901184, "Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02901184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*